A Study on the Effect of 2 Pen Devices on HbA1c

Clinical trial NCT00985712 · COMPLETED

Trial details

NCT number: NCT00985712
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2009-10-01
Primary completion: 2011-07-01
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.